US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Perpetuals.com Ltd

3.10

-0.0800-2.52%

Post-market: 3.120.0200+0.65%19:30 EDT

Volume:13.91K

Turnover:42.98K

Market Cap:21.00M

PE:-3.92

High:3.28

Open:3.17

Low:2.95

Close:3.18

52wk High:8.83

52wk Low:1.90

Shares:6.77M

Float Shares:4.36M

Volume Ratio:0.68

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7902

EPS(LYR):-0.5960

ROE:-98.99%

ROA:-52.19%

PB:4.16

PE(LYR):-5.20

Loading ...

Overview Company News Filings

Statement on a Proposed Transaction with AI Financial Corporation

THOMSON REUTERS

Perpetuals.com Shareholders Approve Stated Capital Reduction at Extraordinary Meeting

Perpetuals.com Announces Ordinary General Meeting of Shareholders

Perpetuals.com signs exchange agreement with Datavault AI to list tokenized commodities

Perpetuals.com announces agreement with Datavault AI to list tokenized assets

Perpetuals reports $4.5 billion UpsideOnly trading volume in first two weeks

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026

Perpetuals.com CEO Patrick Gruhn to present at Emerging Growth Conference

Oncopeptides to spotlight Pepaxti data and PDC strategy at EHA 2026

New Benchmark in Business Aviation Training: Sino Jet Academy Achieves International Dual Certification

Press Release: Unaudited Preliminary Results for the Year Ended December 31, 2025

Darts: PDC aims to reel in Big Fish sponsor in multi-million-pound deal

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026

Perpetuals.com files patent for bias-removal architecture for AI agents

Perpetuals files US patent application for BayesShield AI bias-removal architecture

Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026

Perpetuals.com Director Michael Hilmer acquires shares worth $32,495

Press Release: Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million

Perpetuals.com amends filing, says share issuance under exchange deal completed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PDC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","market":"US","secType":"STK","nameCN":"Perpetuals.com Ltd","latestPrice":3.1,"timestamp":1787342400000,"preClose":3.18,"halted":0,"volume":13910,"hourTrading":{"tag":"盘后","latestPrice":3.12,"preClose":3.1,"latestTime":"19:30 EDT","volume":313,"amount":976.12,"timestamp":1787355006767,"change":0.02,"changeRate":0.006452,"amplitude":0.006452},"delay":0,"changeRate":-0.025157232704402538,"floatShares":4362600,"shares":6774500,"eps":-0.790182,"marketStatus":"Market Closed","change":-0.08,"latestTime":"08-21 16:00:00 EDT","open":3.17,"high":3.28,"low":2.95,"amount":42975.856105,"amplitude":0.103774,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.790182,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":5,"listingDate":1690257600000,"exchange":"NASDAQ","adjPreClose":3.18,"preHourTrading":{"tag":"盘前","latestPrice":3.21,"preClose":3.18,"latestTime":"07:00 EDT","volume":2,"amount":6.49,"timestamp":1787310006943,"change":0.03,"changeRate":0.009434,"amplitude":0.022013},"postHourTrading":{"tag":"盘后","latestPrice":3.12,"preClose":3.1,"latestTime":"19:30 EDT","volume":313,"amount":976.12,"timestamp":1787355006767,"change":0.02,"changeRate":0.006452,"amplitude":0.006452},"volumeRatio":0.6816956604891597},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","floatShares":4362600,"roa":"-52.19%","roe":"-98.99%","lyrEps":-0.596009,"volumeRatio":0.6816956604891597,"shares":6774500,"dividePrice":0,"high":3.28,"amplitude":0.103774,"preClose":3.18,"low":2.95,"week52Low":1.9,"pbRate":"4.16","psRate":"13.63","week52High":8.83,"institutionHeld":0,"latestPrice":3.1,"eps":-0.790182,"divideRate":0,"volume":13910,"delay":0,"ttmEps":-0.790182,"open":3.17,"prevYearClose":6.475,"prevWeekClose":3.05,"prevMonthClose":3.34,"prevQuarterClose":5.9,"fiveDayClose":3.05,"twentyDayClose":3.6,"sixtyDayClose":6.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-16","symbol":"PDC","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PDC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PDC","date":"2026-08-21","current":-3.923147,"percent":0.868966,"low":-20.799035,"twenty":-13.901725,"median":-9.813125,"eighty":-8.565167,"high":-7.275042,"avg":-10.970893,"sd":2.757926,"marketCap":21543027},"quantilePoints":[{"date":"2026-01-23","current":-12.841505,"twenty":-12.726719,"median":-12.554539,"eighty":-12.382359,"marketCap":20820140},{"date":"2026-01-30","current":-9.396756,"twenty":-12.329049,"median":-11.675543,"eighty":-10.201718,"marketCap":15771446},{"date":"2026-02-06","current":-7.275042,"twenty":-12.149167,"median":-9.714799,"eighty":-8.086801,"marketCap":11897223},{"date":"2026-02-13","current":-8.985188,"twenty":-11.515878,"median":-8.985188,"eighty":-7.549471,"marketCap":15130827},{"date":"2026-02-20","current":-8.855994,"twenty":-10.87722,"median":-8.985188,"eighty":-7.579088,"marketCap":14673241},{"date":"2026-02-27","current":-8.742983,"twenty":-10.032842,"median":-8.830662,"eighty":-7.735212,"marketCap":14368184},{"date":"2026-03-06","current":-9.337263,"twenty":-10.032842,"median":-8.985188,"eighty":-8.021273,"marketCap":15191838},{"date":"2026-03-13","current":-9.688387,"twenty":-9.991079,"median":-9.288813,"eighty":-8.290652,"marketCap":15618918},{"date":"2026-03-20","current":-9.233278,"twenty":-9.991079,"median":-9.314811,"eighty":-8.348912,"marketCap":14993551},{"date":"2026-03-27","current":-9.069316,"twenty":-9.96573,"median":-9.348389,"eighty":-8.474222,"marketCap":14581724},{"date":"2026-04-02","current":-9.313761,"twenty":-9.884139,"median":-9.348389,"eighty":-8.689231,"marketCap":15008804},{"date":"2026-04-10","current":-9.533008,"twenty":-9.74834,"median":-9.359515,"eighty":-8.70742,"marketCap":15374872},{"date":"2026-04-17","current":-12.673274,"twenty":-9.884139,"median":-9.362202,"eighty":-8.546978,"marketCap":20438819},{"date":"2026-04-24","current":-13.088049,"twenty":-10.217704,"median":-9.396756,"eighty":-8.70742,"marketCap":21079438},{"date":"2026-05-01","current":-15.050104,"twenty":-11.793949,"median":-9.471088,"eighty":-8.745021,"marketCap":24648605},{"date":"2026-05-08","current":-14.948137,"twenty":-12.890814,"median":-9.496239,"eighty":-8.793369,"marketCap":24526582},{"date":"2026-05-15","current":-13.305836,"twenty":-13.354923,"median":-9.542177,"eighty":-8.845861,"marketCap":21598035},{"date":"2026-05-22","current":-11.365513,"twenty":-13.169042,"median":-9.675854,"eighty":-8.876909,"marketCap":21140450},{"date":"2026-05-29","current":-14.128136,"twenty":-13.74972,"median":-9.719101,"eighty":-8.895541,"marketCap":26275960},{"date":"2026-06-05","current":-12.076178,"twenty":-13.8801,"median":-9.813125,"eighty":-8.952904,"marketCap":22349404},{"date":"2026-06-12","current":-14.872027,"twenty":-13.8801,"median":-9.991079,"eighty":-9.00144,"marketCap":27440229},{"date":"2026-06-18","current":-14.520969,"twenty":-14.245743,"median":-10.18842,"eighty":-9.035091,"marketCap":26709707},{"date":"2026-06-26","current":-11.614912,"twenty":-14.356284,"median":-10.79484,"eighty":-9.128052,"marketCap":21276450},{"date":"2026-07-02","current":-13.769243,"twenty":-14.446364,"median":-10.952611,"eighty":-9.21958,"marketCap":25339979},{"date":"2026-07-10","current":-12.205639,"twenty":-14.446364,"median":-11.365513,"eighty":-9.239186,"marketCap":32585522},{"date":"2026-07-17","current":-8.962642,"twenty":-14.389601,"median":-10.952611,"eighty":-9.21958,"marketCap":23914115},{"date":"2026-07-24","current":-9.476284,"twenty":-14.254526,"median":-10.71246,"eighty":-9.09917,"marketCap":25065786},{"date":"2026-07-31","current":-9.145848,"twenty":-14.247303,"median":-10.285858,"eighty":-9.069924,"marketCap":24862550},{"date":"2026-08-07","current":-7.600862,"twenty":-14.243402,"median":-10.102078,"eighty":-8.962642,"marketCap":20797828},{"date":"2026-08-14","current":-7.895877,"twenty":-14.128136,"median":-9.96573,"eighty":-8.855994,"marketCap":21475282},{"date":"2026-08-21","current":-7.890223,"twenty":-13.901725,"median":-9.813125,"eighty":-8.565167,"marketCap":21543027}],"updateTime":1787510303601},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649938601","title":"Statement on a Proposed Transaction with AI Financial Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938601?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:10","pubTimestamp":1783429806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nFWN4390AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649129679","title":"Perpetuals.com Shareholders Approve Stated Capital Reduction at Extraordinary Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2649129679","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649129679?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:10","pubTimestamp":1783368658,"startTime":"0","endTime":"0","summary":"Perpetuals.com shareholders approve stated capital reduction at extraordinary meetingPerpetuals.com held an extraordinary general meeting on April 30, 2026.Shareholders adopted a proposal to reduce st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL4pK5BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648525033","title":"Perpetuals.com Announces Ordinary General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2648525033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648525033?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:11","pubTimestamp":1782936685,"startTime":"0","endTime":"0","summary":"Perpetuals.com announces ordinary general meeting of shareholdersPerpetuals.com will hold its eighth annual general meeting of shareholders in Tokyo on July 24, 2026.Shareholders will vote on approval","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL7ysWQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640089923","title":"Perpetuals.com signs exchange agreement with Datavault AI to list tokenized commodities","url":"https://stock-news.laohu8.com/highlight/detail?id=2640089923","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640089923?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:11","pubTimestamp":1780431063,"startTime":"0","endTime":"0","summary":"Perpetuals signed a mutual services agreement with Datavault AI to list tokenized real-world commodity assets on its exchange platform.Trading is targeted on PM MTF, an EU-licensed multilateral trading facility operated on Perpetuals’ technology.Initial coverage includes Datavault’s MTB Copper program, with scope to expand into other tokenized commodity programs.Datavault’s covered programs target more than USD 328 million of combined issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL87Mr3z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640945460","title":"Perpetuals.com announces agreement with Datavault AI to list tokenized assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2640945460","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640945460?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:11","pubTimestamp":1780405889,"startTime":"0","endTime":"0","summary":"Perpetuals.com (PDC) announced an agreement with Datavault AI (DVLT) to list tokenized real-world commodity assets on the Perpetuals platform. In i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/perpetuals-com-announces-agreement-with-datavault-ai-to-list-tokenized-assets-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/perpetuals-com-announces-agreement-with-datavault-ai-to-list-tokenized-assets-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","PDC","BK4123","DVLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640491001","title":"Perpetuals reports $4.5 billion UpsideOnly trading volume in first two weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640491001","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640491001?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:03","pubTimestamp":1780401833,"startTime":"0","endTime":"0","summary":"Perpetuals.com reported $4.5 billion in UpsideOnly volume in its first two weeks, across 186,000 fills, 25 instruments, and more than 30,000 active users.Gold led activity with $1.4 billion in volume, ahead of bitcoin at $1.2 billion; precious metals represented about 35% of platform activity.Users came from 185 countries, highlighting broad early adoption of the platform’s “can’t lose” trading and market prediction model.Signed a mutual services agreement with Datavault AI to list tokenized commodity programs, targeting trading on PM MTF Ltd.Initial coverage includes the MTB Copper project; combined targeted issuance across covered programs exceeds $328 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. publis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL9zYzwp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951834","title":"Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951834","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951834?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:05","pubTimestamp":1780315500,"startTime":"0","endTime":"0","summary":"Approximately 80% Major Response Rate and Duration of Response Exceeding 16 Months inSubset Analysis of Patients Treated with Iopofosine I 131 Immediately Post-BTKi Therapy Plans to Initiate Phase 3 C","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304338/29076/en/Cellectar-Biosciences-to-Highlight-Compelling-New-Efficacy-Data-from-Phase-2b-CLOVER-WaM-Study-of-Iopofosine-I-131-in-r-r-Waldenstr%C3%B6m-Macroglobulinemia-at-the-American-Society-of-C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2308191902.HKD","LU2362541513.USD","BK4534","LU2111349929.HKD","LU0158827781.USD","LU0289960550.SGD","LU1989772923.USD","LU2125910336.SGD","LU0472753341.HKD","LU2240825500.USD","LU2463526074.USD","BK4585","LU2092937221.SGD","WM","BK4117","LU0057025933.USD","LU1974910355.USD","LU2229751404.USD","LU2271345857.HKD","LU2413666699.HKD","LU0511384066.AUD","LU0069063385.USD","LU1430594728.SGD","LU0124676726.USD","LU0347712357.USD","BK4120","LU2089283258.USD","CNS","LU1623119135.USD","LU2355687059.USD","BK4566","LU2413666426.HKD","LU2023251221.USD","CLRB","LU1585245621.USD","BK4123","LU2028103732.USD","BK4107","LU1989772840.SGD","BK4588","LU2238339852.HKD","LU1917777945.USD","PDC","LU2089279066.USD","LU0289961442.SGD","AFG","LU2106854487.HKD","LU2125910179.SGD","LU0158827948.USD","LU2041044095.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640935336","title":"Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640935336","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640935336?lang=en_us&edition=fundamental","pubTime":"2026-06-01 14:00","pubTimestamp":1780293600,"startTime":"0","endTime":"0","summary":"Multiple confirmed partial and minor responses observed in patients with SGC Continuing very good safety profile, with removal of the lifetime maximum doxorubicin limit based on highly favorable cardi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304013/0/en/Avacta-presents-updated-clinical-data-showing-encouraging-early-efficacy-signals-for-AVA6000-in-salivary-gland-cancers-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01698","BK4565","BK4571","LU0269904917.USD","BK4563","BK4535","BK4526","IE00BYTNYN87.SGD","LU2039709279.SGD","LU0359202008.SGD","LU0828238088.HKD","BK4108","BK4531","PK","IE00B12V2V27.USD","IE00BYQNZ168.SGD","PDC","SG9999011746.SGD","BK4509","LU1023057109.AUD","LU0509642566.USD","LU0456842615.SGD","TME","LU0359201612.USD","BK4181","BK4548","BK4218","BK4123","BK4552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638909693","title":"Perpetuals.com CEO Patrick Gruhn to present at Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638909693","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638909693?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:29","pubTimestamp":1779971353,"startTime":"0","endTime":"0","summary":"Perpetuals will present at the Emerging Growth Conference on June 10, 2026, at 4:10 p.m. ET.CEO Patrick Gruhn is scheduled to deliver the presentation and take investor questions during the online event.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL1M0CGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638572683","title":"Oncopeptides to spotlight Pepaxti data and PDC strategy at EHA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638572683","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638572683?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:13","pubTimestamp":1779866015,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) has provided an update. Oncopeptides AB will showcase an extensive data package on its peptide-drug conjugate melflu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-to-spotlight-pepaxti-data-and-pdc-strategy-at-eha-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-to-spotlight-pepaxti-data-and-pdc-strategy-at-eha-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2045819591.USD","SGXZ58947870.SGD","LU2177674079.SGD","LU0516422952.EUR","LU0572939691.SGD","SG9999002406.SGD","SG9999013478.USD","SG9999004360.SGD","LU0532188223.SGD","LU0516422366.SGD","LU2360107671.USD","LU2065171311.SGD","LU2065169927.USD","LU0348788117.USD","LU1242518931.SGD","SG9999002604.SGD","LU0261945553.USD","SG9999001135.SGD","LU1861217088.USD","LU0072462343.USD","BK4085","LU0499858438.USD","LU0737861269.HKD","PDC","LU0441851309.USD","LU0345775950.USD","BK4588","LU0516423091.SGD","LU0048573645.USD","SG9999002414.USD","BK4503","LU0264606111.USD","LU0823039010.USD","LU0175139822.USD","BK4585","LU0499858602.USD","SG9999005177.SGD","LU2065171402.SGD","LU0823038988.USD","LU1770036033.HKD","IE0001KFT4U8.USD","LU2125910849.SGD","LU1242518857.USD","BK4551","IE0031814969.USD","LU2065170008.USD","LU1861220207.SGD","LU0210637038.USD","LU1839390173.USD","LU2125910500.SGD","LU0589944569.HKD","LU2238330802.EUR","BK4535","IE0034224299.USD","BK4548","LU0345776255.USD","BK4220","SG9999013486.USD","BK4581","LU0979878070.USD","SG9999006266.SGD","BK4123","LU1048588211.SGD","LU2008162690.USD","SE","SG9999002620.SGD","BK4554","LU0572940350.SGD","SG9999013460.SGD","LU0516423174.USD","LU0251143029.SGD","BK4566","LU0516422440.USD","LU0289960550.SGD","LU2543165471.USD","LU2152927971.USD","SG9999014492.USD","SG9999002679.SGD","IE00BD6J9T35.USD","SG9999014484.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636121488","title":"New Benchmark in Business Aviation Training: Sino Jet Academy Achieves International Dual Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2636121488","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636121488?lang=en_us&edition=fundamental","pubTime":"2026-05-20 16:35","pubTimestamp":1779266100,"startTime":"0","endTime":"0","summary":"HONG KONG, May 20, 2026 /PRNewswire/ -- Recently,Sino Jet Academy's two core training programs — The Corporate Jet Crew program and the Train-the-Trainer Program—each received full accreditation as a dual \"Provider of Training Excellence\" certification from the Professional Development Consortium .PDC is a research organization headquartered in the UK. Its CPD Standards Office has certified more than 800 organizations from over 30 countries to date. The \"Provider of Training Excellence\" certification is based on four core principles: the organization's overall structure and values; the design and delivery of learning content; the organization's mechanisms for maintaining standards and driving continuous improvement; and the overall customer experience and satisfaction . Sino Jet Academy's two programs successfully passed rigorous assessments at the same time, demonstrating that the company's training system and service quality have earned international recognition.Self-Set as the Bench","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2969940/Sino_Jet_New_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2969940/Sino_Jet_New_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/new-benchmark-in-business-aviation-training-sino-jet-academy-achieves-international-dual-certification-302777400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636708887","title":"Press Release: Unaudited Preliminary Results for the Year Ended December 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2636708887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636708887?lang=en_us&edition=fundamental","pubTime":"2026-05-19 14:14","pubTimestamp":1779171240,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, May 19, 2026  -- Avacta Therapeutics , a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated oncology delivery platform today published its unaudited preliminary results for the 12 months ended December 31, 2025 .-- Increased momentum and strengthened position as a pure-play oncology. biopharmaceutical company by focusing on the Company's unique proprietary. pre|CISION peptide drug conjugate platform, with significant progress. -- First patient received treatment in FOCUS-01, a multicenter,open-label Phase 1 clinical trial of AVA6103 (FAP-Exd,-- The FOCUS-01 trial is enrolling patients with six advanced cancers. that were selected by leveraging our strategic collaboration with. -- Presented highly favorable data from multiple preclinical studies. compared to successful antibody drug conjugate, Enhertu. Also. presented further data comparing with another successful antibody. -- Updated preclinical and translational data presented at","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4136","IP","LU1169589451.USD","LU1481600234.SGD","PDC","BK4022","IE00B3T34201.USD","LU1169590202.USD","BK4123","LU1487256676.USD","BK4585","BK4588","LU1481599808.USD","LU2463526074.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634028156","title":"Darts: PDC aims to reel in Big Fish sponsor in multi-million-pound deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2634028156","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634028156?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:38","pubTimestamp":1778503119,"startTime":"0","endTime":"0","summary":"Darts is enjoying a boom thanks in part to the rise of Luke Littler Darts chiefs at the PDC are seeking a multi-million-pound deal to sponsor one of the game’s most iconic moments, the “Big Fish” checkout.The contract will guarantee a brand exposure every time someone makes a 170 checkout – the highest possible, comprising two treble 20s followed by a bullseye – at all Professional Darts Corporation events in the UK and overseas, including the flagship World Championships at Alexandra Palace.UK-headquartered agency Sporting Group International is leading the search for a sponsor and is understood to be seeking seven figures a year on a minimum 24-month contract from a brand in the consumer or lifestyle sector.“The ‘Big Fish’ sponsor is not just a naming rights opportunity, it’s a unique and powerful chance for a brand to own the most celebrated single moment in one of the world’s fastest-growing sports,” said SGI chief executive Adrian Wright.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/05/GettyImages-2227156440-e1778502775947.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/05/GettyImages-2227156440-e1778502775947.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/darts-pdc-aims-to-reel-in-big-fish-sponsor-in-multi-million-pound-deal/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/darts-pdc-aims-to-reel-in-big-fish-sponsor-in-multi-million-pound-deal/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634289402","title":"Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634289402","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634289402?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:05","pubTimestamp":1778501100,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., May  11, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291850/29076/en/Cellectar-Biosciences-to-Report-First-Quarter-Financial-Results-and-Host-a-Conference-Call-on-Thursday-May-14-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","LU2463526074.USD","LU2362540622.SGD","BK4120","BK4566","LU0124676726.USD","WM","LU1585245621.USD","BK4533","LU0289960550.SGD","LU1721428933.USD","LU1917777945.USD","LU0175139822.USD","BK4218","BK4181","LU1989772923.USD","LU2362541513.USD","BK4123","BK4135","LU2089279066.USD","LU2092937221.SGD","PDC","LU0347712357.USD","BK4585","LU2125910179.SGD","CLRB","HST","LU1923621640.USD","BK4534","CNS","LU0094547139.USD","LU1623119135.USD","LU2413666426.HKD","LU2355687059.USD","LU2271345857.HKD","BK4588","LU0289961442.SGD","LU2089284900.SGD","LU0472753341.HKD","LU1974910355.USD","LU2362541273.HKD","LU2023250504.SGD","LU1430594728.SGD","LU2106854487.HKD","LU0069063385.USD","LU0158827948.USD","LU1803068623.USD","LU1892829315.USD","LU2041044095.USD","LU2229751404.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633140369","title":"Perpetuals.com files patent for bias-removal architecture for AI agents","url":"https://stock-news.laohu8.com/highlight/detail?id=2633140369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633140369?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:56","pubTimestamp":1778158585,"startTime":"0","endTime":"0","summary":"Perpetuals.com (PDC) has filed a U.S. patent application covering BayesShield AI, a system that identifies which AI model or human expert performs ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/perpetuals-com-files-patent-for-bias-removal-architecture-for-ai-agents-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/perpetuals-com-files-patent-for-bias-removal-architecture-for-ai-agents-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","BK4023","BK4123","PDC","BK4543","BK4588","BK4585","BK4528","AIPO","CHAT","AIYY","AI","BK4551","BK4587","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633141050","title":"Perpetuals files US patent application for BayesShield AI bias-removal architecture","url":"https://stock-news.laohu8.com/highlight/detail?id=2633141050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633141050?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:01","pubTimestamp":1778155317,"startTime":"0","endTime":"0","summary":"Perpetuals filed a U.S. patent application covering BayesShield AI, a real-time routing system designed to select best-performing AI model or human expert for a given decision context.System targets reliability gap between benchmark results and production performance, aiming to strengthen risk controls for enterprise agentic AI deployments.Framework continuously scores performance across decision “regimes,” then directs tasks to top performers only when conditions match prior results.Company positioned use cases across decision-heavy sectors such as financial trading, fraud detection, cybersecurity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via Bus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL8XLSGy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633906805","title":"Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633906805","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633906805?lang=en_us&edition=fundamental","pubTime":"2026-05-06 14:00","pubTimestamp":1778047200,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, May  06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, \"the Company\", \"Avacta\"), a clinical stage biopharmaceutical company developing pre|CISION,a tumor-activated ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288498/0/en/Avacta-presents-new-comparisons-of-pre-CISION-payload-release-vs-approved-ADCs-and-AVA6207-dual-payload-delivery-at-Science-Day-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123","TSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633926477","title":"Perpetuals.com Director Michael Hilmer acquires shares worth $32,495","url":"https://stock-news.laohu8.com/highlight/detail?id=2633926477","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633926477?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:11","pubTimestamp":1778011891,"startTime":"0","endTime":"0","summary":"Perpetuals.com director Michael Anthony Hilmer reported open-market purchases of 4,000 American depositary shares.Total reported buy prices ranged from USD 7.97 to USD 8.20 per ADS.Beneficial ownership rose to 4,000 ADS following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL7Kncsr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Perpetuals.com Director Michael Hilmer acquires shares worth $32,495","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145449","title":"Press Release: Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145449","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145449?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978800,"startTime":"0","endTime":"0","summary":"Oversubscribed Financing Led by Nantahala Capital with Participation from Balyasny Asset Management, Caligan Partners, Janus Henderson Investors, SilverArc Capital Management, Stonepine Capital Management, Empery Asset Management LP, StemPoint Capital LP and other Dedicated Healthcare Funds along with Members of the Executive Management Team. Financing of up to $140 Million Supports Confirmatory Study and NDA Filing for Accelerated Approval of Iopofosine I 131 in Waldenstrm Macroglobulinemia with the FDA. Andrew Gu of Nantahala Capital Management, LLC to Join the Company's Board of Directors Upon Closing. FLORHAM PARK, N.J., May 05, 2026  --  Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted oncology therapies, today announced that it has entered into a securities purchase agreement with certain institutional investors, and an additional securities purchase agreement with certain members of management, to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413666426.HKD","LU2111349929.HKD","03160","LU2355687059.USD","LU0069063385.USD","LU2125910179.SGD","LU2362540622.SGD","BK4585","LU2023250843.SGD","LU2229751404.USD","TM","LU1712237335.SGD","LU1917777945.USD","LU0124676726.USD","LU0094547139.USD","LU2125910336.SGD","LU1923621640.USD","LU0175139822.USD","BK4120","LU0158827948.USD","CLRB","LU0289960550.SGD","LU1989772840.SGD","LU0347712357.USD","BK4588","CNS","LU2106854487.HKD","BK4099","LU2240825500.USD","LU0511384066.AUD","PDC","LU2089284900.SGD","LU2413666699.HKD","BK4604","LU2362541513.USD","WM","BK4533","LU2238339852.HKD","LU2089283258.USD","LU0472753341.HKD","LU1939255532.USD","BK4555","LU0158827781.USD","BK4534","BK4135","BK4566","LU1989772923.USD","LU2023250504.SGD","LU1623119135.USD","LU2463526074.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632647818","title":"Perpetuals.com amends filing, says share issuance under exchange deal completed","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647818","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632647818?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:10","pubTimestamp":1777666254,"startTime":"0","endTime":"0","summary":"Perpetuals.com filed an amended Form 6-K to update disclosure on its share exchange with Perpetual Markets.Share issuance to Perpetual shareholders under Share Exchange Agreement dated Dec. 28, 2025 has been completed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL4y0LWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":74,"code":"91000000","status":"200"}]}}